Cargo Therapeutics (Cargo Therapeutics) Equity-to-Asset : 0.90 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cargo Therapeutics Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cargo Therapeutics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $405.39 Mil. Cargo Therapeutics's Total Assets for the quarter that ended in Dec. 2023 was $453.04 Mil.

The historical rank and industry rank for Cargo Therapeutics's Equity-to-Asset or its related term are showing as below:

CRGX' s Equity-to-Asset Range Over the Past 10 Years
Min: -3.44 Med: -0.04 Max: 0.9
Current: 0.9

During the past 3 years, the highest Equity to Asset Ratio of Cargo Therapeutics was 0.90. The lowest was -3.44. And the median was -0.04.

CRGX's Equity-to-Asset is ranked better than
85.89% of 1566 companies
in the Biotechnology industry
Industry Median: 0.665 vs CRGX: 0.90

Cargo Therapeutics Equity-to-Asset Historical Data

The historical data trend for Cargo Therapeutics's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cargo Therapeutics Equity-to-Asset Chart

Cargo Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Equity-to-Asset

-0.04

-3.44

0.90

Cargo Therapeutics Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial			-	-3.44	-1.24	-1.33	0.90

Competitive Comparison of Cargo Therapeutics's Equity-to-Asset

For the Biotechnology subindustry, Cargo Therapeutics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cargo Therapeutics's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cargo Therapeutics's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cargo Therapeutics's Equity-to-Asset falls into.

Cargo Therapeutics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cargo Therapeutics's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	405.386	/	453.036
	=

Cargo Therapeutics's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	405.386	/	453.036
	=

Cargo Therapeutics (NAS:CRGX) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Cargo Therapeutics Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cargo Therapeutics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Cargo Therapeutics (Cargo Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cargo Therapeutics Inc (NAS:CRGX) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1900 Alameda De Las Pulgas, Suite 350, San Mateo, CA, USA, 94403

Website

https://www.cargo-tx.com

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing strategy are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. Their lead program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

Cargo Therapeutics (Cargo Therapeutics) Headlines

From GuruFocus

CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors

By Marketwired • 04-15-2024